Seidu S, Cos X, Brunton S, et al
Take your first step towards a happier and healthier lifestyle
, L-
Lilly is building a multi-engine growth machine: Alzheimer's Treatment Kisunla (Donanemab) - FDA-approved for early Alzheimer's, first proven to slow cognitive decline Represents a breakthrough in neurodegenerative disease treatment Oncology & Immunology Verzenio (breast cancer): $1.47B in Q3 2025 (+7% YoY) Jaypirca and Omvoh expanding in oncology and autoimmune markets Radiopharmaceutical investments through Point Biopharma ($1.4B acquisition) and Aktis Oncology partnership Pipeline Depth 40+ programs in Phase 2/3 across neuroscience, immunology, and cardiology Recent acquisitions: Scorpion Therapeutics, SiteOne Therapeutics, Adverum Biotechnologies Lilly isn't a one-trick pony
Our BPC-157 research compound is 100% pure, containing no fillers, additives, or extraneous substancesjust high-purity BPC-157 peptide for laboratory use
How to Price and Package Peptide Services the Right Way Your pricing needs to reflect the true costs, not just the product or injections
